ALPHA-2A ADRENERGIC RECEPTOR
OrganismNot specified
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 118–149 | Fragment:SECOND INTRACELLULAR LOOP (RESIDUES 118-149) Mutation:D130I | No other associated polymer | SOLUTION NMR NMR measurement conditions:pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM NACL NMR measurement conditions:pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM NMR sample composition:0.9 mM PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 | 90% H2O/10% D2O NMR sample composition:0.9 mM PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 | 100% D20 | Resolution not provided |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 1HO9 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1HLL NMR STRUCTURE OF T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA-2A ADRENERGIC RECEPTOR Deposited 2000-12-01 | Different construct Different mutation/modification Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
118–149(32 aa)
Fragment:SECOND INTRACELLULAR LOOP T3-I2 (RESIDUES 118-149)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM NaCl
NMR sample composition
0.9 mM T3-I2 natural abundance; 460 mM D38-dodecylphosphocholine, 50 mM NaCl, 10 mM NaH2PO4, pH 4.5 | 90% H2O/10% D2O
NMR sample composition
0.9 mM T3-I2 natural abundance; 460 mM D38 dodecylphosphocholine, 50 mM NaCl, 10 mM NaH2PO4, pH 4.5 | 100% D2O
|
Resolution not provided |
| 1HOD NMR STRUCTURE OF D130I MUTANT T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA 2A ADRENERGIC RECEPTOR Deposited 2000-12-10 | Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
118–149(32 aa)
Fragment:SECOND INTRACELLULAR LOOP (RESIDUES 118-149)
|
Mutation:D130I | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM NACL
NMR measurement conditions
pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM
NMR sample composition
0.9 mM PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 | 90% H2O/10% D2O
NMR sample composition
0.9 mM PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 | 100 % D20
|
Resolution not provided |
| 1HOF NMR STRUCTURE OF T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA-2A ADRENERGIC RECEPTOR Deposited 2000-12-10 | Different mutation/modification Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
118–149(32 aa)
Fragment:SECOND INTRACELLULAR LOOP (RESIDUES 118-149)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM NACL
NMR measurement conditions
pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM
NMR sample composition
0.9 MM T3-I2 PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 | 90% H2O/10% D2O
NMR sample composition
0.9 MM T3-I2 PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 | 100% D2O
|
Resolution not provided |
| 6K42 cryo-EM structure of alpha2BAR-Gi1 complex Deposited 2019-05-23 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 5 PDB declaration: pentameric |
Chain R
1–27(27 aa)
|
Not recorded | CZX 4-[(1~{S})-1-(2,3-dimethylphenyl)ethyl]-1~{H}-imidazole × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.10 Å |
| 7EJ0 Structure of the alpha2A-adrenergic receptor GoA signaling complex Deposited 2021-04-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain R
1–465(465 aa)
|
Not recorded | E5E Noradrenaline × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 7EJ8 Structure of the alpha2A-adrenergic receptor GoA signaling complex bound to brimonidine Deposited 2021-04-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain R
1–465(465 aa)
|
Not recorded | J59 Brimonidine × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å |
| 7EJA Structure of the alpha2A-adrenergic receptor GoA signaling complex bound to dexmedetomidine Deposited 2021-04-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain R
1–465(465 aa)
|
Not recorded | CZX 4-[(1~{S})-1-(2,3-dimethylphenyl)ethyl]-1~{H}-imidazole × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å |
| 7EJK Structure of the alpha2A-adrenergic receptor GoA signaling complex bound to oxymetazoline Deposited 2021-04-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain R
1–465(465 aa)
|
Not recorded | J5C Oxymetazoline × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å |
| 7W6P Cryo-EM structure of the alpha2A adrenergic receptor GoA signaling complex bound to a G protein biased agonist Deposited 2021-12-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain R
1–465(465 aa)
|
Not recorded | W96 N-pyridin-4-ylisoquinolin-4-amine × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.47 Å |
| 7W7E Cryo-EM structure of the alpha2A adrenergic receptor GoA signaling complex bound to a biased agonist Deposited 2021-12-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain R
1–465(465 aa)
|
Not recorded | W58 5-(3-bicyclo[4.2.0]octa-1,3,5-trienyl)-1,2,3,6-tetrahydropyridine × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å |
| 9CBL Cryo-EM structure of epinephrine-bound alpha-2A-adrenergic receptor in complex with heterotrimeric Gi-protein Deposited 2024-06-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain R
35–242(208 aa)
Chain R
380–460(81 aa)
|
Not recorded | ALE L-EPINEPHRINE × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å |
| 9CBM Cryo-EM structure of dexmedetomidine-bound alpha-2A-adrenergic receptor in complex with heterotrimeric Gi-protein Deposited 2024-06-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain R
35–242(208 aa)
Chain R
380–460(81 aa)
|
Not recorded | CZX 4-[(1~{S})-1-(2,3-dimethylphenyl)ethyl]-1~{H}-imidazole × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 9IQR Cryo-EM structure of MT3-alpha2AAR Deposited 2024-07-13 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
38–241(204 aa)
Chain B
379–456(78 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen NITROGEN
|
Resolution 3.40 Å |
| 9PLN Locally-refined structure of alpha2a adrenergic receptor in complex with Go heterotrimer, scFv16, and N-(5-methylnaphthalen-1-yl)pyridin-4-amine (compound 4905) Deposited 2025-07-15 | Different construct Different mutation/modification Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain R
2–465(464 aa)
|
Not recorded | A1CIU N-(5-methylnaphthalen-1-yl)pyridin-4-amine × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;CHS was solubilized in LMNG and GDN prior to diluting into buffers.
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å |
| 9PLO Structure of alpha2a adrenergic receptor in complex with Go heterotrimer, scFv16, and N-(5-methylnaphthalen-1-yl)pyridin-4-amine (compound 4905) Deposited 2025-07-15 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain R
2–465(464 aa)
|
Not recorded | A1CIU N-(5-methylnaphthalen-1-yl)pyridin-4-amine × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;CHS was solubilized in LMNG and GDN prior to diluting into buffers.
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.74 Å |
| 9PQD Locally-refined structure of alpha2a adrenergic receptor in complex with Go heterotrimer, scFv16, and compound Z7149 Deposited 2025-07-22 | Different construct Different mutation/modification Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain R
2–465(464 aa)
|
Not recorded | A1CIZ (6M)-1-methyl-6-(1,2,5,6-tetrahydropyridin-3-yl)-1H-indole × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;Buffer was supplemented with 0.01 mM compound Z7149
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.29 Å |
16 other PDB entries and 16 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | ADA2A_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–32; UniProt 118–149 |